Medtech recalls 108,000 tins of Sucrets; Mission Pharmacal buys transdermal patch maker;

> Fresenius Kabi is recalling 5,488 bags of Kabiven 3.9% lipid emulsion over labeling issues. Notice

> Medtech Pharma is recalling 107,832 tins of Insight Pharmaceuticals' Sucrets lozenges over labeling issues. Notice

> Mylan ($MYL) is recalling 7,722 bottles of mycophenolic acid delayed-release tablets that failed specifications for dissolution. Notice

> San Antonio,TX-based Mission Pharmacal has acquired for an undisclosed sum the assets of transdermal patch maker, Miami, FL-based ProSolus Pharmaceuticals. Release

And Finally... Canada has gotten drugs and ingredients from nearly 300 foreign drug facilities that have self inspected or been inspected by consultants they hired. Story

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.